GWPH News and Press, GW Pharmaceuticals Plc From 01/24/21

Cannabis sales are determined by number of dispensaries and the availability to them by proximity. California has no restrictions regarding the number of dispensaries such as Washington State. Growth in cannabis in California will eclipse the entire cannabis industry's current ret...

Recently announced provisional Q4 numbers are positive. Company has provided new information in recent conferences on product testing as the pipeline develops. Numerous potential revenue opportunities opening up for 2021 and beyond. For further details see: GW Pharma Wel...

Cannabis companies are starting to turn a profit and print positive EPS. Here are the few that are earning a profit. Many companies are close to turning a positive EPS. The industry itself is expected to expand some 100% in the next couple of years, and with economies of scale, th...

The cannabis sector is poised for great growth due to potential for more permissive regulations. US MSOs are better situated to gain from new regulations than their Canadian counterparts. An actively managed ETF play can be a good solution to avoid specific stocks in a turbulent s...

I recommended OVID for OV935 but disliked OV101. In December, OVID fell drastically after OV101's failure. OV935 thesis still stands, however, the numbers are now different. This article was written after some asked for my current opinion on the stock. For further details se...

The cannabis stocks are rallying as Aphria (APHA) beat revenue and earnings for the second quarter of fiscal 2021 ahead of its merger with Tilray ([[TLRY]] +23.5%) scheduled for the second quarter of 2021.For the seventh quarter in succession, Aphria’s gross revenue for ...

The Democratic win that joined the wave of state legalization is encouraging for the cannabis market. Based on their most recent quarterly filing, Canopy Growth (NASDAQ:CGC), Cronos Group (NASDAQ:CRON), GW Pharmaceuticals (NASDAQ:GWPH), Aphria (NASDAQ:APHA) that announced it will merge with...

The following slide deck was published by GW Pharmaceuticals plc in conjunction with this event. For further details see: 39th Annual JPMorgan Virtual Healthcare Conference

GW Pharmaceuticals plc. (GWPH) 39th Annual JPMorgan Virtual Healthcare Conference January 12, 2021, 10:00 AM ET Company Participants Justin Gover - Chief Executive Officer Darren Cline - U.S. Chief Commercial Officer Chris Tovey - Chief Operating Officer Scott Giacobello - Chief Financial Off...

The newly constituted Senate gives a green light for cannabis. Vice-President elect Kamala Harris sponsored the More Act in the Senate. Removing cannabis entirely as a scheduled substance from the Controlled Substances Act is a financial godsend to cannabis companies. Get read...